Author: jezzabellemente

KUALA LUMPUR, Nov 21 (Bernama) — Nanjing IASO Biotechnology Co Ltd (IASO Bio) made its debut at the Sixth China International Import Expo (CIIE) with FUCASO, the world’s first fully-human chimeric antigen receptor T-cell (CAR-T).

In a statement, the company said it has also entered into a strategic partnership with several international medical institutions, bringing hope for cure to multiple myeloma (MM) patients worldwide.

The China National Medical Products Administration (NMPA) approved the marketing of FUCASO’s Equecabtagene Autoleucel Injection for the treatment of adult patients with relapsed or refractory multiple myeloma (r/rMM), on June 30.

Meanwhile, the injection has received the Orphan Drug Designation, as well as the Regenerative Medicine Advanced Therapy and Fast Track Designations from the United States (US) Food and Drug Administration, and has been approved for clinical trials in the US.

A single infusion of FUCASO can lead to lasting and deep remission with a favourable safety profile in patients with r/rMM who have failed multiple lines of therapy.

Due to its unique design, FUCASO, as a fully-human CAR-T therapy, is able to persist in patients for a longer period of time, offering hope for overcoming the challenging problem of relapsed MM.

FUCASO has attracted patients from numerous countries around the world to seek treatment in Chinese hospitals in just four months since its approval for marketing in China.

These hospitals have a world-leading level of full-process management in CAR-T therapy, in addition to the cost of treatment with FUCASO in China is significantly lower than that of similar products in Europe and America, which has benefitted more patients worldwide.

— BERNAMA

AsiaNet 100501

^{The launch ceremony}

FUZHOU, China, Nov. 20, 2023 /Xinhua-AsiaNet/–

The 8th Maritime Silk Road (Fuzhou) International Tourism Festival kicked off in Fuzhou, Fujian Province, China on 17th November. The festival in Fuzhou is sponsored by the Ministry of Culture and Tourism of the People’s Republic of China and the People’s Government of Fujian Province. It is hosted by the Department of Culture and Tourism of Fujian Province and Fuzhou Municipal People’s Government.

The festival showcases Fuzhou’s active participation in the Belt and Road Initiative by inviting nearly 500 guests to take part in related activities in the city. These guests include representatives from international organisations, the World Tourism Alliance, the International Mountain Tourism Alliance, and representatives of friendly cities of co-building countries, all working together to enhance the impact of the Maritime Silk Road (Fuzhou), according to Fuzhou Municipal Bureau of Culture and Tourism.

This year’s festival is emphasising international characteristics, unique aspects of the Maritime Silk Road, and the fusion of culture and tourism. The main events include the festival’s launch ceremony and cultural tourism dialogue, the Fujian Tourism Expo 2023, and the grand cultural and tourism experience event “Maritime Silk Road-Themed Wonders Night”, showcasing a diverse array of Fuzhou’s culture as an international brand. The festival highlights distinctive aspects of Fuzhou’s culture, including the historical and cultural significance of Yantai Mountain, hot springs, Fujian cuisine, ancient houses, and intangible cultural heritage, all contributing to showcasing the charm of Fuzhou.

The Maritime Silk Road (Fuzhou) International Tourism Festival marks a significant milestone for Fujian Province and Fuzhou City in their efforts to comprehensively develop and construct a central area that will play a key role in the “21st Century Maritime Silk Road”. The festival has been held for seven consecutive years since it began in 2015, offering a new platform for regional cooperation, promotion, and collaboration among participating countries to learn from and benefit each other. It has evolved into an internationally influential tourism conference.

Source: Fuzhou Municipal Bureau of Culture and Tourism

Image Attachments Links:

   Link: https://iop.asianetnews.net/view-attachment?attach-id=443298

   Caption: The launch ceremony

BARCELONA, Spain, Nov 17 (Bernama-GLOBE NEWSWIRE) — The Qatari capital will host the third edition of the region’s leading urban innovation event from 29-30 November. Under the motto “A World of Data: Connecting People, Elevating Lives”, Smart City Expo Doha (SCE Doha) will lead the debate on sustainable urban development and the importance of data in building smarter, more liveable cities. Organized by the Qatar Ministry of Communications and Information Technology (MCIT), SCE Dohais an event of Smart City Expo World Congress and Fira Barcelona International, the event will feature more than 70 speakers, over 100 countries represented and 40 companies and organizations, and will be held within the International Horticulture Exhibition of Qatar, that will take place at Al-Bidda Park.

The centrepiece of Smart City Expo Doha 2023 will be a conference featuring more than 70 experts, including Renée Cummings, Founder & CEO, Urban AI, Columbia University Community Scholar; Ott Velsberg, Chief Data Officer at the Government of Estonia; and Frans-Anton Vermast, Strategy Advisor & International Smart City Ambassador in Netherlands, who will share their vision on four main themes: Green Urban Environments, Digital Governance, Cognitive Cities, and Liveable Places.

The 40 companies, partners and sponsors will present their new products and solutions in the field of urban innovation, both at the congress and in the networking space that will foster commercial relations, professional contacts and business opportunities between participating companies and visitors.

Smart City Expo Doha is part of the internationalization strategy of Smart City Expo World Congress, the world’s leading exhibition on smart cities and urban solutions organized annually by Fira de Barcelona, which held its 13th edition last November. Along these lines, foreign editions have been held in 2023 in Argentina, Brazil, Colombia, the United States, Mexico and China.

http://mrem.bernama.com/viewsm.php?idm=47545

KUALA LUMPUR, Nov 15 (Bernama) — The Malaysian Institute of Accountants (MIA) has expanded its definition of Public Interest Entities (PIEs) to hold audit firms to higher ethical and independence standards, thereby raising audit quality and ultimately strengthening good governance and trust. The revised definition of PIEs along with other relevant changes are set to come into effect on 15 December 2024.

The expanded definition of PIEs consists of entities such as publicly traded entities, entities which are primarily deposit-taking from the public, entities involved in providing insurance to the public or entities specifically designated as PIE by legal, regulatory or professional standards. “This broadening of scope ensures that audit firms are held to higher ethical and independence standards as the audits of PIEs are subject to additional independence requirements,” stated MIA President Datuk Bazlan Osman, commenting on the revision. “This is very much aligned with MIA’s increased emphasis on ethics to enable strong regulation and good governance.”

The revised definition of PIEs along with other relevant changes are part of updates issued by the MIA to its By-Laws (on Professional Ethics, Conduct and Practice). These changes are aligned with the latest standards issued by the International Ethics Standards Board for Accountants (IESBA).

“The revisions encourage audit firms to determine if other entities should also be treated as PIEs by assessing several factors such as an entity’s importance in the sector it operates in and the potential systemic impact on other sectors and the economy as a whole in the event of financial failure of an entity,” explained MIA Ethics Standards Board Chair Dr. Veerinderjeet Singh.

The revisions also clarify why additional independence requirements exist for the audit of PIEs. “Given that there is a significantly greater interest in the financial health of such entities, there is a corresponding expectation of the level of independence an audit firm should have when performing the audit of a PIE,” added Dr. Veerinderjeet.

“To strengthen compliance and value of PIE audits, it is important that professional accountants be cognisant of the more stringent independence requirements when auditing PIEs,” advised Dr. Veerinderjeet. Some of these requirements would involve partner rotations, restrictions on fee dependency and restrictions on the provision of certain non-assurance services.

The Institute encourages all accountancy professionals, organisations, and stakeholders to familiarise themselves with the expanded definition of a PIE. “The enhanced PIE definitions represent an important step in maintaining public trust and highlight the vital role that professional accountants play in maintaining independence, integrity and objectivity when working with public interest clients,” concluded Datuk Bazlan.

The updated By-Laws and the detailed PIE revisions are available on the MIA website whilst related resources can be found on the IESBA website.

About the Malaysian Institute of Accountants (MIA)

Established under the Accountants Act 1967, MIA is the national accountancy body that regulate, develops, supports and enhances the integrity, status and interests of  the  profession  in  Malaysia. MIA accords the Chartered Accountant Malaysia or C.A. (M) designation. Working closely alongside businesses, MIA connects its membership to a wide range of information resources, events, professional development and networking opportunities. Presently, there are more than 38,500 members making their strides in  businesses across all industries in Malaysia  and around the world.

MIA’s international outlook and connections are reflected in its membership of regional and international professional organisations such as the International Federation of Accountants  (IFAC)  and  the  ASEAN  Federation  of  Accountants  (AFA).   For   more   information  on  MIA, visit www.mia.org.my

SOURCE: Malaysian Institute of Accountants (MIA)

FOR MORE INFORMATION, PLEASE CONTACT:
MIA STRATEGY COMMUNICATIONS & BRANDING
NAME: THANE MEYYAPPAN
TEL: +60122489534
NAME: MOHD FAIZ OTHMAN
TEL: +60126225027
EMAIL: communications@mia.org.my 

–BERNAMA

London, Nov 14 (Bernama- GLOBE NEWSWIRE) — London, UK – November 14, 2023 – OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, will be presenting innovative research at the upcoming ISPOR Europe conference in Copenhagen, Denmark. OPEN Health experts will contribute to the event through workshops, panel discussions, and 24 posters. Key themes of OPEN Health’s research presented this year are patient preference, advanced modeling methodologies, and HTA policy changes. The majority of OPEN Health’s Scientific Office will be onsite to discuss the role of HEOR science in shaping policy, including Dr. Elisabeth Fenwick, Chief Scientific Officer; Professor Ben van Hout, Scientific Founder; Dr. Marco Boeri, Director of Preference Research and scientific lead for Patient-Centered Outcomes; Emanuele Arcà, MSc, Senior Research Consultant in Strategic Market Access; and Maarten Treur, MSc, Vice President and Global Head of Modeling & Meta-Analysis.

Dr. Elisabeth Fenwick, Chief Scientific Officer at OPEN Health, said: “I am extremely proud to see the research we do at OPEN Health being presented by our scientific experts at the ISPOR EU conference in Copenhagen. The range of research topics covered this year shows the extent of our expertise in advanced techniques as well as key therapeutic areas.”

Dr. Marco Boeri, Director of Preference Research and scientific lead for Patient-Centered Outcomes at OPEN Health, said: “The importance of patient preference information is that it brings a systematic approach to implement the idea of patient-focused drug development promoted by the FDA, the EMA, and various HTA bodies around the world. Indeed, the patient voice is key to patient adherence, and by helping to understand unmet needs, it is key to the success of a pharmaceutical product.”

Emanuele Arcà, MSc, Senior Research Consultant in Strategic Market Access, said: “We are in a dynamic period of policy changes for access and HTA across regional, national, and international settings. HTA is taking a more prominent role in ensuring sustainable access to health innovations, while health innovations become exponentially more complex and expensive. We at OPEN Health are committed to understanding and shaping such changes through research and stakeholder engagement.”

OPEN Health will be presenting a virtual panel on November 10, ahead of ISPOR, on: “EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025.” The panel is set to discuss several policy aspects regarding the current challenges and implications of the EU HTA regulation, covering topics such as the current position of EU HTA implementation, the major challenges expected across the industry, the stance of member states and various stakeholders, and strategies for the industry to prepare for joint clinical assessments. Register now to save your seat.

To learn more about our presence at ISPOR Europe, visit our website or meet the OPEN Health team at booth #C2-012 in Copenhagen.

About OPEN Health

OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being. Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. OPEN Health is a flexible global organization that solves complex healthcare challenges across consulting, HEOR and market access, scientific communications, patient engagement, and creative omnichannel communications. For more information on OPEN Health, visit www.openhealthgroup.com.

Press contact:

OPEN Health

Candice Subero, Vice President, Global Marketing

candicesubero@openhealthgroup.com

Attachment

· OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

Candice Subero
OPEN Health
candicesubero@openhealthgroup.com
 
Source: Open Health

–BERNAMA